Comorbid conditions and gender impact the primary survival of distal radio-cephalic arteriovenous fistula in patients on long-term hemodialysis

Journal of Nephrology

Volumn 18, Issue 3, 2005, Pages 276-281

  Vernaglione, Luigi ^a,b   Mele, Giuseppe ^a   Cristofano, Claudio ^a   Distratis, Cosimo ^a   Perrone, Franco ^a   Frascina, Marcello ^a   Pennacchiotti, Fabio ^a   Chimienti, Stefano ^a  

^a Nephrology and Dialysis Unit   (Italy)

^b NONE   (Italy)

Author keywords

Autologous vascular access survival; Comorbidities; Hemodialysis; Vascular access failure

Indexed keywords

C REACTIVE PROTEIN; HEPARIN; LIPID;

ADULT; AGE; AGED; ARTICLE; BLOOD CLOTTING; CATHETERIZATION; COHORT ANALYSIS; COMORBIDITY; CONFIDENCE INTERVAL; CONTROLLED STUDY; COVARIANCE; DEATH; DISEASE SEVERITY; FEMALE; FIBRINOLYTIC THERAPY; GENDER; HEMATOCRIT; HEMODIALYSIS; HUMAN; KAPLAN MEIER METHOD; KIDNEY ARTERIOVENOUS FISTULA; KIDNEY FAILURE; KIDNEY TRANSPLANTATION; LIPID BLOOD LEVEL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PERITONEAL DIALYSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; STATISTICAL MODEL; SURVIVAL; THROMBOCYTE COUNT; THROMBOSIS; VASCULAR ACCESS;

ARTERIOVENOUS SHUNT, SURGICAL; CATHETERS, INDWELLING; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; INCIDENCE; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIAL ARTERY; RENAL DIALYSIS; RISK FACTORS; SEX DISTRIBUTION; SEX FACTORS; THROMBOSIS; TREATMENT FAILURE;

EID: 23144442044     PISSN: 11218428     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Feldman HI, Held PJ, Hutchinson JT, Stoiber E, Hartigan MF, Berlin J. Hemodialysis vascular access morbidity in the United States. Kidney Int 1993; 43: 1091-6.
2. US Renal Data System. X. The cost-effectiveness of alternative types of vascular access and the economic cost of ESRD. Am J Kidney Dis 1995; 26 (suppl 2): S140-56.
3. Feldman HI, Kobrin S, Wasserstein A. Hemodialysis vascular access morbidity. J Am Soc Nephrol 1996; 7: 523-5.
4. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 2000; 37 (suppl 1): S137-81.
5. Allon M, Ornt DB, Schwab SJ, Rasmussen C, Delmez JA, Greene T, Kusek JW, Martin AA, Minda S. Factors associated with the prevalence of arteriovenous fistulas in hemodialysis patients in the HEMO Study. Hemodialysis (HEMO) Study Group. Kidney Int 2000; 58: 2178-85.
6. Pisoni RL, Young EW, Dykstra DM, Greenwood RN, Hecking E, Gillespie B, Wolfe RA, Goodkin DA, Held PJ. Vascular access use in Europe and the United States: Results from the DOPPS. Kidney Int 2002; 61: 305-16.
7. Hakim R, Himmelfarb J. Hemodialysis access failure: A call to action. Kidney Int 1998; 54: 1029-40.
8. Dixon BS, Novak L, Fangman J. Hemodialysis vascular access survival: Upper-arm native arteriovenous fistula. Am J Kidney Dis 2002; 39: 92-101.
9. Masaki T, Yorioka N, Kyuden Y, Yamashita K, Taniguchi Y, Yamakido M, Tanaka J, Harada S. Factors influencing arteriovenous fistula dysfunction in Japanese patients on chronic hemodialysis. Int J Artif Organs 1999; 22: 14-7.
10. Miller PE, Tolwani A, Luscy CP, Deierhoi MH, Bailey R, Redden DT, Allon M. Predictors of adequacy of arteriovenous fistulas in hemodialysis patients. Kidney Int 1999; 56: 275-80.
11. Ravani P, Marcelli D, Malberti F. Vascular access surgery managed by renal physicians: The choice of native arterio-venous fistulas for hemodialysis. Am J Kidney Dis 2002; 40: 1264-76.
12. Ravani P, Brunori G, Mandolfo, S, Cancarini G, Imbasciati E, Marcelli D, Malberti F. Cardiovascular comorbidity and late referral impact arteriovenous fistula survival: A prospective multicenter study. J Am Soc Nephrol 2004; 15: 204-9.
13. Miskulin DC, Athienites NV, Yan G, Martin AA, Ornt DB, Kusek JW, Meyer KB, Levey AS, Hemodialysis (HEMO) Study Group. Comorbidity assessment using the index of coexistent diseases in a multicenter clinical trial. Kidney Int 2001; 60: 1498-510.
14. Miskulin DC, Meyer KB, Martin AA, Fink NE, Coresh J, Powe NR, Klag MJ, Levey AS, Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Comorbidity and its change predict survival in incident dialysis patients. Am J Kidney Dis 2003; 41: 149-61.
15. Daugirdas JT. Second generation logarithmic estimates of single-pool variable volume Kt/V: An analysis of error. J Am Soc Nephrol 1993; 4: 1205-13.
16. Dhingra RK, Young EW, Hulbet-Shearon TE, Leavey SF, Port FK. Type of vascular access and mortality in U.S. hemodialysis patients. Kidney Int 2001; 60: 1443-51.
17. Stevenson KB, Hannah EL, Lowder CA, Adcox MJ, Davidson RL, Mallea MC, Narasimhan N, Wagnild JP. Epidemiology of hemodialysis vascular access infections from longitudinal infection surveillance data: Predicting the impact of NKF-DOQI Clinical Practice Guidelines for Vascular Access. Am J Kidney Dis 2002; 39: 549-55.
18. Rayner HC, Pisoni RL, Gillespie BW, Goodkin DA, Akiba T, Akizawa T, Saito A, Young EW, Port FK, Dialysis Outcomes and Practice Patterns Study. Creation, cannulation and survival of arteriovenous fistulae: Data from the Dialysis Outcomes and Practice Patterns Study. Kidney Int 2003; 63: 323-30.
19. Astor BC, Coresh J, Powe NR, Eustace JA, Klag MJ. Relation between gender and vascular access complications in hemodialysis patients. Am J Kidney Dis 2000; 36: 1126-34.
20. Miller CD, Robbin ML, Allon M. Gender differences in outcomes of arteriovenous fistulas in hemodialysis patients. Kidney Int 2003; 63: 346-52.